(Q45932087)

17 December 2017

title

Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. (English)

1 reference

17 December 2017

1 reference

1 reference

4

1 reference

17 December 2017

Juan-Manuel Anaya

9

1 reference

17 December 2017

Yehuda Shoenfeld

13

object named as

Yehuda Shoenfeld

1 reference

17 December 2017

6

Miri Blank

1 reference

17 December 2017

14

Nancy Agmon Levin

1 reference

17 December 2017

3

Boris Gilburd

1 reference

17 December 2017

5

Maya Ram

1 reference

17 December 2017

10

Nicola Bizzaro

1 reference

17 December 2017

1

Yinon Shapira

1 reference

17 December 2017

12

Jan Damoiseaux

1 reference

17 December 2017

Johan Frostegard

8

object named as

Johan Frostegård

1 reference

17 December 2017

author name string

Bat-Sheva Poratkatz

2

1 reference

17 December 2017

Staffan Lindeberg

7

1 reference

17 December 2017

Luis J Jara

11

1 reference

17 December 2017

publication date

1 April 2012

1 reference

17 December 2017

Clinical Reviews in Allergy & Immunology

published in

1 reference

17 December 2017

volume

42

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

154-163

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s12016-010-8241-z

exact match

0 references

cites work

Predicting and preventing autoimmunity, myth or reality?

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Definition of human autoimmunity--autoantibodies versus autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Autoantibodies as predictors of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Natural evolution, prediction, and prevention of type 1 diabetes in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Mycobacterium tuberculosis, autoimmunity, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Viral infection can induce the production of autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Infections and autoimmunity--friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology of autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Defining and analyzing geoepidemiology and human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Effects of tobacco smoke on immunity, inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Environmental factors and the geoepidemiology of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The epidemiology of transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The implications of autoimmunity and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Epigenetics and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The immune effects of naturally occurring and synthetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Drugs and autoimmunity--a contemporary review and mechanistic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The complement system in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The environment, geoepidemiology and ANCA-associated vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology: the environment and spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology of autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology of autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of autoimmune intestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Travels and travails of autoimmunity: a historical journey from discovery to rediscovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Light, including ultraviolet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology of myasthenia gravis [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiologic considerations of auto-immune pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Multiple sclerosis: Geoepidemiology, genetics and the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The geoepidemiology of autoimmune muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Coordination of tolerogenic immune responses by the commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Autoimmune kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The worldwide gradient of autoimmune conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Nutrition, geoepidemiology, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

21 January 2018

Stress and autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Hepatitis C and interferon induced thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geo-epidemiology and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Geoepidemiology of COPD and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Molecular mimicry: a critical look at exemplary instances in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Molecular mimicry and auto-immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Molecular mimicry in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Prevalence of hepatitis C serum antibody in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Infectious antibodies in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Autoantibodies in nonautoimmune individuals during infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Crossreactivity of human anti-dsDNA antibodies to phosphorylcholine: clues to their origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

A prospective study of the incidence of childhood celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Infections may have a protective role in the etiopathogenesis of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Ethnic and geographical variation in antiphospholipid (Hughes) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Clinical relevance of antiprothrombin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Antiphospholipid antibodies, antiphospholipid syndrome and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8241-Z

Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis

21 January 2018

1 reference

12 December 2020

A latitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia

1 reference

12 December 2020

Common infectious agents prevalence in antiphospholipid syndrome

1 reference

12 December 2020

Antinuclear autoantibodies in sera of healthy pregnant women and their offspring

1 reference

12 December 2020

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

1 reference

12 December 2020

Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing

1 reference

12 December 2020

Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods

1 reference

12 December 2020

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

1 reference

12 December 2020

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

12 December 2020

Natural autoantibodies in the serum of healthy women--a five-year follow-up

1 reference

12 December 2020

The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution

1 reference

12 December 2020

Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies

1 reference

12 December 2020

Prevalence of yaws on Kar Kar Island, New Guinea

1 reference

12 December 2020

10.1007/S12016-010-8241-Z

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1014239456

0 references

1 reference

17 December 2017